Holding of 2026 Q1 Earnings Conference Call (IR)
- Holding an online IR session on May 26, 2026 at 4:00 PM for 2026 Q1 earnings release and business update
- Main content: 2026 Q1 earnings review, key business status and outlook, Q&A session
- Target: Investors, securities analysts, etc.
- IR materials will be posted on KRX KIND system and company website
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Holding of Investor Relations Conference (IR)
- Company: Optipharm (153710)
- Submission: Optipharm.CO.,LTD
- Receipt: 05-20-2026
- Under KRX KOSDAQ Market Division